Matches in Wikidata for { <http://www.wikidata.org/entity/Q64725659> ?p ?o ?g. }
Showing items 1 to 50 of
50
with 100 items per page.
- Q64725659 description "clinical trial" @default.
- Q64725659 description "ensayu clínicu" @default.
- Q64725659 description "klinisch onderzoek" @default.
- Q64725659 description "клінічне випробування" @default.
- Q64725659 name "BI 1356 (Linagliptin) in Combination With Metformin and a Sulphonylurea in Type 2 Diabetes" @default.
- Q64725659 type Item @default.
- Q64725659 label "BI 1356 (Linagliptin) in Combination With Metformin and a Sulphonylurea in Type 2 Diabetes" @default.
- Q64725659 prefLabel "BI 1356 (Linagliptin) in Combination With Metformin and a Sulphonylurea in Type 2 Diabetes" @default.
- Q64725659 P1050 Q64725659-AE1C6C64-C8BB-453D-AE6A-1518DB8E2324 @default.
- Q64725659 P1132 Q64725659-61A70421-3E70-4D53-BD15-2519C95A44F5 @default.
- Q64725659 P1476 Q64725659-4F632FA4-BF61-4458-827A-FB0007C433E1 @default.
- Q64725659 P17 Q64725659-035BB18D-A813-4AE6-908E-1F0B74931BED @default.
- Q64725659 P17 Q64725659-06CF4F7B-ABAD-41F0-8AAA-DEC1F72A3756 @default.
- Q64725659 P17 Q64725659-5CE8E325-D006-4F22-B8D3-E70F92BEBB38 @default.
- Q64725659 P17 Q64725659-6A99B093-945F-4106-B8E9-1B6BBD8AF6B2 @default.
- Q64725659 P17 Q64725659-74B98108-AF2C-40B3-ACE2-602B3909E3C3 @default.
- Q64725659 P17 Q64725659-DAE2E713-D240-48CF-A488-129B26F37A56 @default.
- Q64725659 P17 Q64725659-EA2A801E-4519-473D-A709-E58CE8B4D5F5 @default.
- Q64725659 P17 Q64725659-FCD33E7B-5E02-4864-A6A4-42C9B587D31A @default.
- Q64725659 P2899 Q64725659-96C124C6-FC46-4461-A343-052D86DE407C @default.
- Q64725659 P3098 Q64725659-A6E5808C-C377-4F2A-B139-9265C2DA9704 @default.
- Q64725659 P31 Q64725659-49815B8A-D0FA-4506-BF25-7EBA972877DC @default.
- Q64725659 P4135 Q64725659-2738955A-B61B-4DEA-97D9-19DAE19EC43F @default.
- Q64725659 P4844 Q64725659-0FA4618C-2C43-46CB-8A49-EE65C282B293 @default.
- Q64725659 P4844 Q64725659-89447609-690C-47D8-B930-EC4C1B20AF89 @default.
- Q64725659 P580 Q64725659-BA71D0CD-6B22-4F77-9A3B-4E6437857AD2 @default.
- Q64725659 P582 Q64725659-3EEAF07E-9472-4978-9060-EB9738BC61E3 @default.
- Q64725659 P6099 Q64725659-7D72FEEB-F130-4C58-B2BD-92E8DBC66296 @default.
- Q64725659 P8363 Q64725659-CF41E279-EDD5-4DB4-B346-19DFA834F0B8 @default.
- Q64725659 P1050 Q12206 @default.
- Q64725659 P1132 "+1058" @default.
- Q64725659 P1476 "A Randomised, Double-blind, Placebo-controlled Parallel Group Efficacy and Safety Study of BI 1356 (5 mg) Administered Orally Once Daily Over 24 Weeks, With an Open-label Extension to One Year (Placebo Patients Switched to BI 1356), in Type 2 Diabetic Patients With Insufficient Glycaemic Control Despite a Therapy of Metformin in Combination With a Sulphonylurea" @default.
- Q64725659 P17 Q145 @default.
- Q64725659 P17 Q16 @default.
- Q64725659 P17 Q183 @default.
- Q64725659 P17 Q31 @default.
- Q64725659 P17 Q414 @default.
- Q64725659 P17 Q43 @default.
- Q64725659 P17 Q865 @default.
- Q64725659 P17 Q928 @default.
- Q64725659 P2899 "+18" @default.
- Q64725659 P3098 "NCT00602472" @default.
- Q64725659 P31 Q30612 @default.
- Q64725659 P4135 "+80" @default.
- Q64725659 P4844 Q19484 @default.
- Q64725659 P4844 Q909745 @default.
- Q64725659 P580 "2008-02-01T00:00:00Z" @default.
- Q64725659 P582 "2009-05-01T00:00:00Z" @default.
- Q64725659 P6099 Q42824827 @default.
- Q64725659 P8363 Q78089383 @default.